HIV Care Grant Program - Part B States/Territories Formula and AIDS Drug Assistance Program Formula and AIDS Drug Assistance Program Supplemental Awards

The HIV Care Grant Program - Part B States/Territories Formula and AIDS Drug Assistance Program Formula and AIDS Drug Assistance Program Supplemental Awards is administered by the Health Resources and Services Administration within the U.S. Department of Health and Human Services. This federal program operates under the broader Ryan White HIV/AIDS Program framework, which is designed to support access to medical care and essential support services for individuals living with HIV who are uninsured or underinsured. The program reflects a longstanding federal commitment to improving health outcomes and reducing disparities among low-income populations affected by HIV across the United States and its territories. The primary purpose of this funding opportunity is to provide financial resources to states and eligible territories to develop, maintain, and enhance comprehensive systems of high-quality HIV care and treatment. The program emphasizes improving access to medical services, medications, and supportive services that are necessary for effective HIV management. A key component of the funding includes support for AIDS Drug Assistance Programs, which help ensure that eligible individuals can obtain life-saving HIV medications. Supplemental funding is also included to address emerging needs and disparities, particularly through Minority AIDS Initiative funding streams. Funds awarded under this program are intended to support a wide range of allowable activities that contribute to a coordinated system of care. These may include outpatient medical care, pharmaceutical assistance, case management, and other support services that enable individuals to remain engaged in care. While the specific allocation and use of funds are governed by federal program rules, the overarching requirement is that expenditures must directly support the delivery and accessibility of HIV-related care and treatment services. There is no cost sharing or matching requirement associated with this opportunity, which lowers barriers to participation for eligible applicants. Eligibility for this program is limited to state governments and certain U.S. territories explicitly identified in the program guidance. These include the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. Additional jurisdictions such as the Northern Mariana Islands, American Samoa, and several Pacific Island entities are also eligible under related funding notices. This eligibility structure reflects the formula-based nature of the program, where funding allocations are determined according to statutory criteria tied to HIV prevalence and other factors. The application process is expected to follow standard federal grant submission procedures, requiring applicants to submit their materials electronically by the specified deadline. Applications must be submitted through the appropriate federal grants system by 11:59 p.m. Eastern Time on the due date. While specific application components are not detailed in the forecast notice, applicants should anticipate requirements typical of federal health funding programs, such as program narratives, budgets, and compliance documentation. The timeline for this opportunity indicates that it is currently in a forecast stage, with an estimated posting date in late July 2026 and an anticipated application deadline in October 2026. Awards are expected to be issued by April 2027, with project activities beginning immediately thereafter. The program aligns with the federal fiscal year 2027 cycle. Interested applicants may direct questions to the listed program contact, Erin Nortrup, via phone or email for additional guidance as more detailed application materials become available.